Case by Case | Abbott secures UPC-wide Preliminary Injunction over Continuous Glucose Monitoring patent

Melissa Dix discusses a Milan Local Division (LD) decision from 7 September today. The LD granted Abbott a UPC-wide PI against the Chinese company SiSensing and four of its subsidiaries. Abbott is the main supplier of Continuous Glucose Monitoring (CGM) products for diabetes in the UPC contracting member states. The Court found it more likely than not that the defendants’ CGM product infringed Abbott’s patent and rejected the validity challenges at the provisional stage. Keep up with mo...